Be Ready to Handle Rxs for Direct Oral Anticoagulants for Cancer Patients

Some patients with cancer will get a direct oral anticoagulant (DOAC), such as Xarelto or Lixiana, for a blood clot.

Patients with cancer tend to be at higher risk of blood clots compared to noncancer patients.

Injectable low-molecular-weight heparins (LMWH), such as dalteparin (Fragmin) or enoxaparin (Lovenox), are usually the go-to blood thinners to treat blood clots in patients with cancer.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote